NCT04617821 2022-01-28AG vs mFOLFIRINOX as Neoadjuvant Therapy for Borderline Reseactable and Locally Advanced Pancreatic CancerFudan UniversityPhase 3 Unknown300 enrolled
NCT02717091 2020-09-10Neoadjuvant FOLFIRINOX or Nab-paclitaxel With Gemcitabine for Borderline Resectable Pancreatic CancerNagoya UniversityPhase 2 Unknown50 enrolled